Navigation Links
Cell Therapeutics Retires Remaining Convertible Debt
Date:12/18/2011

ntrone to prove safe and effective for the treatment of relapsed or refractory non-Hodgkin's lymphoma and/or other tumors as determined by the U.S. Food and Drug Administration and/or the European Medicines Agency, that one or more of CTI's product candidates may be approved in 2012, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Media Contact:

Dan Eramian
T: 206.272.4343
C: 206.854.1200
E: deramian@ctiseattle.com

Investors Contact:

Ed Bell
T: 206.272.4345
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.CellTherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amsterdam Molecular Therapeutics Announces Negative Equity Position
2. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
3. Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin
4. Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
5. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
6. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
7. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
8. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
9. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... FL (PRWEB) , ... August 04, 2015 , ... ... of rapid point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, ... Dr. Gregg has more than 30 years of relevant experience and remarkable achievements ...
(Date:8/4/2015)... 4, 2015  Blueprint Medicines (NASDAQ: BPMC ), ... drugs for genomically defined diseases, today announced that ... company overview at the 2015 Wedbush PacGrow Healthcare Conference ... A live webcast of the event will ... Blueprint Medicines website at www.blueprintmedicines.com . An archived ...
(Date:8/4/2015)... ... 2015 , ... On August 4, 2015, the White House will host a ... the United States to talk about their experiences with innovation and present their big ... among the attendees. , One of the day’s aims is to grow the innovation ...
(Date:8/4/2015)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... today announced that it will release its unaudited financial ... after market close on Wednesday, August 12, 2015. The Company ... 2015, at 8:00 a.m. EDT (Thursday, August 13, 2015 ... Company,s financial results and provide an update on recent ...
Breaking Biology Technology:RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2
... I am familiar with bad jobs. , ,My youngest brother ... involved wandering through unfamiliar neighborhoods, worrying about making a daily ... a shared apartment. After a few weeks of this, my ... brother once found a job selling environmentally friendly household products, ...
... the seed capital he needs to fuel his rapidly growing ... are legally allowed to make angel investments. , ,This is ... Wisconsins tech community, Peter M. Skanavis is doing everything he ... angel investments to actually take the plunge and put their ...
... stories coming out of California, but the failure of flight ... one of the weirdest. , ,The radio system used by ... a snit when its regular monthly maintenance wasnt performed and ... but couldnt talk to them, even as the planes converged ...
Cached Biology Technology:Beware the cold-call job interview 2Beware the cold-call job interview 3Beware the cold-call job interview 4Beware the cold-call job interview 5Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 2Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 3Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 4Proactive nightmares 2
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... a reason to be glad about madder: The climbing plant has ... Rice University and the City College of New York have discovered ... of purpurin, an organic dye that can be turned into a ... used since ancient times to create dye for fabrics. ...
... Troy, N.Y. A new study from engineering researchers ... how the little-understood protein osteocalcin plays a significant role ... lead to new strategies and therapeutics for fighting osteoporosis ... by the U.S. National Institutes of Health, the study ...
... Asian soybean rust ( Phakopsora pachyrhizi ) pose a ... because they can be blown great distances by the ... to determine whether these spores are viable. "Finding ... and able to infect plants," said USDA Agricultural Research ...
Cached Biology News:Rice cultivates green batteries from plant 2Rice cultivates green batteries from plant 3Battling brittle bones... with broccoli and spinach? 2Dead or alive? A new test to determine viability of soybean rust spores 2
APG5 autophagy 5-like (S. cerevisiae)...
Human Jagged 2 Biotinylated Affinity Purified PAb...
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
Griess Reagent component for determination of nitrite in aqueous solutions....
Biology Products: